Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
about
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growthEarly detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenograftsRadiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETMonitoring early responses to irradiation with dual-tracer micro-PET in dual-tumor bearing mice.[18F]FLT PET for non-invasive assessment of tumor sensitivity to chemotherapy: studies with experimental chemotherapy TP202377 in human cancer xenografts in mice[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice.The role of DNA synthesis imaging in cancer in the era of targeted therapeuticsDevelopment of radiotracers for oncology--the interface with pharmacologyPET imaging of early response to the tyrosine kinase inhibitor ZD4190.3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.Targeted molecular imaging in oncology: focus on radiation therapy.(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors.Crossroads in the combined-modality management of gastroesophageal junction carcinomas.In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PETIncreased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft modelIn-vivo Comparison of 18F-FLT uptake, CT Number, Tumor Volume in Evaluation of Repopulation during Radiotherapy for Lung cancer.Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.Animal tumor models for PET in drug development.Nucleoside-based probes for imaging tumor proliferation using positron emission tomography.The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models.DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation.FDG and Beyond.Biological imaging in clinical oncology: radiation therapy based on functional imaging.Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.Correlations of (18)F-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci.Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.Comparison of FLT-PET and FDG-PET for visualization of head and neck squamous cell cancers.
P2860
Q27661276-8CBF9F90-6E33-4000-8F18-E6474386428FQ28475583-78EF6B54-ABE2-40E1-A8B0-7925A7D59CCFQ28484852-DE2CCB20-3DC2-4C76-9BAF-1B316676A3B4Q34235986-E072324D-F64F-4FB9-951D-E61E1F448CF0Q34333124-5D4FA2D5-374A-43DD-A969-63F7F0FCFC2CQ34505642-5334FDF0-AD2E-4E7A-8823-E8E32590194FQ34645445-04AD0884-C622-40B2-A17F-DC8B5F4CD679Q34907192-FE68530C-F68A-40F3-9C6B-9A30D890E849Q35195500-74AA6FA4-68BF-4AE8-8FCE-B04D1F849D48Q35249646-F459FC0D-364E-47A2-9621-DC54950678D8Q36217442-E8C6D3D1-805B-480E-92C2-C0B302C4D10BQ36528175-51EC9D20-780B-4522-BDFF-97E9B8C5062FQ36563521-58365369-1998-4087-8BDE-98CD098CEBF2Q37076597-0EF1188D-AFDB-44CC-8AF7-992270F2096DQ37077354-83042037-D097-4DD1-9B84-23FD1E98424CQ37211631-2E484959-B55F-44D3-86ED-BCFC7551B426Q37741083-93D0FCE4-0AAC-42D8-AB70-72E1BE677615Q37837982-D0AC7F2D-BE13-4914-B3DF-3B24777B2EC7Q37847721-67AB807C-C551-4E90-A2C3-A4B484B6B267Q37924161-FEC40A5C-0377-4596-B067-9D2187219979Q38166979-8AC9A234-32D5-481B-BE5F-05A2DDAF2AB1Q38226697-EF23DD00-48F0-4607-AAD8-D04FA554E1BAQ38340518-25DBD2F4-EDE5-463B-BC25-E931CD419010Q38475122-CBE7D5AA-926B-4F51-AE79-143273AEDB01Q38780973-0EEC59AD-DECB-43F7-BD67-4DCB9567000BQ38869438-0946B097-DD6F-4C7A-8C32-EA25A34FDF73Q38887987-1FD75D46-F6E9-4CE3-B182-AD2884B87D22Q46867338-7F8AC3BD-C2FA-4B1E-B777-70AA147AAD52Q47442773-096B2658-ACA1-4596-A69D-4D7612600C42Q50053211-065294F0-474A-4AAC-A211-A01E186A1479Q53122101-ECA1758A-1667-47C4-B63F-23B51A564C17Q53295575-E3FF6591-08DF-43DD-B5CF-FCD8CD15818B
P2860
Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Early detection of chemoradior ...... sing preclinical tumor models.
@en
type
label
Early detection of chemoradior ...... sing preclinical tumor models.
@en
prefLabel
Early detection of chemoradior ...... sing preclinical tumor models.
@en
P2093
P1476
Early detection of chemoradior ...... sing preclinical tumor models.
@en
P2093
Dongmei Han
Firas Mourtada
Hisanori Ariga
Jaffer A Ajani
Juri G Gelovani
K S Clifford Chao
Luka Milas
Mian M Alauddin
Osama Mawlawi
Smith Apisarnthanarax
P304
P356
10.1158/1078-0432.CCR-05-2720
P407
P577
2006-08-01T00:00:00Z